Isopropenylboronic Acid - CAS 14559-87-6
Catalog: |
BB060604 |
Product Name: |
Isopropenylboronic Acid |
CAS: |
14559-87-6 |
Synonyms: |
Prop-1-en-2-ylboronic Acid; (1-Methylethenyl)boronic Acid; 2-Propenylboronic Acid; (1-Methylethenyl)boronic Acid; 1-Propene-2-boronic Acid; B-(1-Methylethenyl)boronic Acid |
IUPAC Name: | prop-1-en-2-ylboronic acid |
Description: | Isopropenylboronic Acid is a reagent used in various synthetic preparations. |
Molecular Weight: | 85.9 |
Molecular Formula: | C3H7BO2 |
Canonical SMILES: | B(C(=C)C)(O)O |
InChI: | InChI=1S/C3H7BO2/c1-3(2)4(5)6/h5-6H,1H2,2H3 |
InChI Key: | WCONKKYQBKPMNZ-UHFFFAOYSA-N |
Melting Point: | >62°C (dec.) |
Solubility: | DMSO (Slightly), Methanol (Slightly) |
Appearance: | Off-White to Light Beige Solid |
Storage: | Amber Vial, -20°C Freezer, Under inert atmosphere |
References: | Matteson, D.S., et al. J. Am. Soc., 82, 4228 (1960); Molander, G.A., et al. J. Am. Soc., 125, 11148 (2003). |
GHS Hazard Statement: | H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P354+P338, P317, P319, P321, P330, P332+P317, P362+P364, P403+P233, P405, and P501 |
Signal Word: | Danger |
Publication Number | Title | Priority Date |
CN-113735888-A | Synthetic method of isopropenyl pinacol borate | 20210906 |
WO-2022006412-A2 | Conjugates of ampk inhibitors and protac degraders and related uses | 20200702 |
WO-2021239117-A1 | Modified proteins and protein degraders | 20200528 |
WO-2021115225-A1 | Pyrazole-containing polycyclic derivative inhibitor, preparation method therefor and application thereof | 20191210 |
TW-202128693-A | Pyrazole-containing polycyclic derivative inhibitor, preparation method therefor and application thereof | 20191210 |
WO-2021113809-A1 | Arylamides and methods of use thereof | 20191205 |
WO-2021018003-A1 | Egfr inhibitor, composition, and preparation method therefor | 20190726 |
WO-2021003339-A1 | Amp-activated protein kinase inhibitors and methods of making and using the same | 20190703 |
WO-2021000855-A1 | Malt1 inhibitors and uses thereof | 20190701 |
TW-202115077-A | Malt1 inhibitors and uses thereof | 20190701 |
PMID | Publication Date | Title | Journal |
18543990 | 20080704 | Synthesis and evaluation of the cytotoxicity of apoptolidinones A and D | The Journal of organic chemistry |
Complexity: | 59.8 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 86.0539096 |
Formal Charge: | 0 |
Heavy Atom Count: | 6 |
Hydrogen Bond Acceptor Count: | 2 |
Hydrogen Bond Donor Count: | 2 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 86.0539096 |
Rotatable Bond Count: | 1 |
Topological Polar Surface Area: | 40.5Ų |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Other Building Blocks
-
[29278-68-0]C34H30O8
1,4-Butanediol Terephthalate Dibenzyl Ester
-
[138381-83-6]C21H23NO6
4,6-O-Benzylidene-N-Cbz-1-deoxynojirimycin
-
[866594-61-8]C7H10O4
(3aS,4R,6aR)-Tetrahydro-4-methoxyfuro[3,4-b]furan-2(3H)-one
-
[131149-12-7]C15H24O6
(4Z)-4-Deoxy-4-[2-(1,1-dimethylethoxy)-2-oxoethylidene]-2,3-O-(1-methylethylidene)-β-L-erythro-pentopyranoside Methyl Ether
-
[1212679-29-2]C28H27FN4O4
(3R,4R)-N-(3-Cyanophenyl)-3-[[4-[(4-fluorophenyl)methoxy]benzoyl]amino]hexahydro-4-hydroxy-1H-azepine-1-carboxamide
-
[1354469-76-3]C7H16N2
(3R,4R)-N,4-Dimethyl-piperidin-3-amine
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS